Metraipolis › archive › dc_38aba216260b
Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report — Europe PMC PMID:42499568
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42499568
- DOI
- 10.3389/fped.2026.1869089
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T23:19:45.338Z
- SHA-256 of the archived text
60c3e84bdea239248bddc2c1fa3f2783dec0237a0e91c8a28c3dbf5b93af0f22- Stable URL of this page
https://metraipolis.com/documento/dc_38aba216260b
How to cite
Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report — Europe PMC PMID:42499568 — Europe PMC (en), https://europepmc.org/article/MED/42499568 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38aba216260b (Metraipolis archive dc_38aba216260b, sha256 60c3e84bdea239248bddc2c1fa3f2783dec0237a0e91c8a28c3dbf5b93af0f22)
BibTeX
@misc{dc38aba216260b,
title = {Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report — Europe PMC PMID:42499568},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42499568},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38aba216260b; sha256 60c3e84bdea239248bddc2c1fa3f2783dec0237a0e91c8a28c3dbf5b93af0f22},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42499568. Agents can read the archived copy with the MCP tool read_document.